Data have suggested that FOXP3 expression in tumor cells could be a poor prognostic factor in breast cancer [6], colorectal cancer [4], and bladder cancer [7], indicating FOXP3 significantly contributed to tumor progression. Here, FOXP3 is linked to urinary bladder carcinoma.